Cambridge Investment Research Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21,100	Closed	-$112K	–	1855
2016 Q3	$112K	Buy	21,100 +3,000	+17%	+$15.9K	﹤0.01%	1666
2016 Q2	$120K	Buy	18,100 +5,000	+38%	+$33.1K	﹤0.01%	1465
2016 Q1	$61K	Hold	13,100	–	–	﹤0.01%	1547
2015 Q4	$66K	Buy	+13,100	New	+$66K	﹤0.01%	1518